Trump's got some news about his favorite "fat drug."
Yes, "fat drugs" like Novo Nordisk's Ozempic and Eli Lilly's Zepbound will be drastically discounted so people on Medicare with weight issues can lose weight without breaking the bank.
From Axios:
Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk to cut prices for blockbuster diabetes and anti-obesity drugs.
...
The manufacturers have agreed to cut the price Medicare pays for GLP-1s it already covers for diabetes and other indications to $245 per dose.
That's about one-ninth of the current list price for the drugs, according to a senior administration official. Medicare spent $5.7 billion on GLP-1s to treat diabetes in 2022, per KFF.
Music to my ears!
More:
Coverage will be newly available to seniors who are severely obese with a body mass index of greater than 35, along with those who are overweight and have prediabetes or cardiovascular disease, and those who are obese and have advance kidney disease, heart failure or uncontrolled hypertension.
Medicare enrollees will pay only a $50 copay out of pocket for GLP-1s, officials said.
Donald Trump: The most fat-phobic president in modern history.
P.S. Now check out our latest video 👇
